Quick Takeaways
- Skylands Capital, LLC filed SCHEDULE 13G for CytoSorbents Corporation Common Stock (CTSO).
- Disclosed ownership: 4.8%.
- Date of event: 31 Mar 2025.
Skylands Capital, LLC - 31 Mar 2025 SCHEDULE 13G Report for CytoSorbents Corporation Common Stock (CTSO)
- Filing Manager
- Skylands Capital, LLC
- Reporting Manager
- Skylands Capital, LLC
- Symbol
- CTSO
- Shares outstanding
- 62,556,292 shares
- Disclosed Ownership
- 3,002,702 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G
- Filing time
- 17 Apr 2025, 14:22:59 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 07 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Skylands Capital, LLC disclosed 4.8% ownership in CytoSorbents Corporation Common Stock (CTSO) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 07 Jan 2025.
- Current filing was accepted on 17 Apr 2025, 14:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Skylands Capital, LLC | 4.8% | 3,002,702 | 3,002,702 | 0 | /s/ Virginia E. Shaffar | Virginia E. Shaffar Vice President & Treasurer |